Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista médica de Chile
versión impresa ISSN 0034-9887
Resumen
LEGUES, María Eugenia et al. High risk cytogenetic abnormalities in patients with multiple myeloma. Rev. méd. Chile [online]. 2019, vol.147, n.1, pp.61-64. ISSN 0034-9887. http://dx.doi.org/10.4067/S0034-98872019000100061.
Background:
Cytogenetic abnormalities observed in the bone marrow of patients with multiple myeloma (MM) are an important prognostic factor for risk stratification.
Aim:
To investigate karyotype characteristics and frequency of the high-risk cytogenetic abnormalities t(4;14), t(14;16) and del(17p) in Chilean patients with MM.
Material and Methods:
We studied 30 patients with MM by conventional cytogenetics (CC) and fluorescent in situ hybridization of plasma cells selected using cytoplasmic immunoglobulin staining (cIg-FISH).
Results:
Overall, the two techniques in combination allowed us to identify clonal genetic abnormalities in 47% of patients. The t(4;14) abnormality was observed in 19% of patients, del(17p) was observed in 10% of patients, and t(14;16) was not detected.
Conclusions:
Our results showed frequencies of high-risk abnormalities similar to those reported abroad. Cytogenetic studies should be performed routinely for all MM patients at the moment of diagnosis.
Palabras clave : Chromosome Aberrations; Cytogenetics; Multiple Myeloma.
